The Early Days of the Commons | GenomeWeb

There have already been some interesting discussions in PubMed Commons, according to NCBI Insights, a blog from the National Center for Biotechnology Information. In a post, it notes that one week into beta phase, there have been 100 comments made in the forum, the same amount that were made over the whole of the development phase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.